Product Information

IMIQUIMOD 5% CREAM PACKET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.6119 per EA under NDC 45802036862. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Sep 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IMIQUIMOD 5% CREAM PACKET

Imiquimod
$0.6119per EA

Strength

12.5 mg/.25g

NDC

45802036862

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

IMIQUIMOD

Approval Type

Generic (ANDA)

FDA Application

ANDA078837

FDA Approved

9/7/2010

TE Code

AB

On Market Since

11/9/2010

Pharmacological Classes

Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers

Price Statistics

The NADAC for IMIQUIMOD 5% CREAM PACKET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6119 per EA
All-time high$13.4311 (Feb 12, 2014)
All-time low$0.5940 (Oct 21, 2026)
52-week high$0.7039
52-week low$0.5940
Median price$1.1186
Average price$2.5408
Largest weekly change+38.5% (Oct 23, 2019)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+3.0%

1M

+0.3%

3M

-5.1%

6M

-12.0%

1Y

-15.9%

3Y

-14.6%

5Y

-40.3%

All

-94.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMIQUIMOD 5% CREAM PACKET?

The current National Average Drug Acquisition Cost (NADAC) for IMIQUIMOD 5% CREAM PACKET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.6119 per EA (NDC 45802036862), effective Nov 18, 2026.

How has the price of IMIQUIMOD 5% CREAM PACKET changed over time?

Over the history we have for it, the NADAC for IMIQUIMOD 5% CREAM PACKET has declined 94.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for IMIQUIMOD 5% CREAM PACKET?

Since Nov 28, 2013, the NADAC for IMIQUIMOD 5% CREAM PACKET has ranged from a low of $0.5940 (Oct 21, 2026) to a high of $13.4311 (Feb 12, 2014), with a median of $1.1186 per EA.

Are there cheaper alternatives to IMIQUIMOD 5% CREAM PACKET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IMIQUIMOD 5% CREAM PACKET in a comparable dosage form, but none are currently priced below it.

Who manufactures IMIQUIMOD 5% CREAM PACKET?

IMIQUIMOD 5% CREAM PACKET (NDC 45802036862) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.